Clinical Research Directory

Inclusion Criteria: A participant is eligible for inclusion in the study if they meet the following criteria: * Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent. * Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR). * Have undergone a self-reported oculo-visual examination within the past two years. * Have no active ocular disease. * Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule. * Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment. * The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form. Exclusion Criteria: A participant will be excluded from the study if they meet any of the following conditions: * Have any systemic disease that affects ocular health. * Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health. * Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine. * Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine. * Have known developmental delays. * Have participated in another clinical study in the last 7 days